AIDS Linked to the IntraVenous Experience (ALIVE)

Welcome to ALIVE

The AIDS Linked to the Intravenous Experience (ALIVE) Study is a long-standing community-based research effort that includes past and current people who inject drugs (PWIDs).

ALIVE has been ongoing since 1988 and is one of the longest-running community-based cohorts of IDUs in existence. The primary objectives when the study started were to characterize the incidence and natural history of HIV among people who inject drugs (PWIDs). Since 1998, the research objectives have evolved to include characterization of access to and impact of treatment for HIV, evaluation of non-AIDS outcomes among an aging cohort as well as ascertainment of the incidence, natural history and treatment of co-infections such as hepatitis C virus and hepatitis B virus. Importantly, the ALIVE study serves as a platform for numerous other research studies focused on PWIDs in Baltimore. These range in scope from focusing on HIV associated co-infections and comorbidities (e.g., HCV, HBV, liver, renal, pulmonary, cardiovascular, malignant, neurocognitive, metabolic and psychiatric diseases, and geriatric syndromes [multimorbidity, frailty, reduced physical function]) to intervention studies.

We are accepting new  participants to the  ALIVE Study! Call us at 410-955-7510 to learn about the study, get screened for eligibility, and schedule an intake appointment! You will be compensated for your time.